BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tu H, Sun L, Dong X, Gong Y, Xu Q, Jing J, Bostick RM, Wu X, Yuan Y. A Serological Biopsy Using Five Stomach-Specific Circulating Biomarkers for Gastric Cancer Risk Assessment: A Multi-Phase Study. Am J Gastroenterol. 2017;112:704-715. [PMID: 28323271 DOI: 10.1038/ajg.2017.55] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Huang RJ, Epplein M, Hamashima C, Choi IJ, Lee E, Deapen D, Woo Y, Tran T, Shah SC, Inadomi JM, Greenwald DA, Hwang JH. An Approach to the Primary and Secondary Prevention of Gastric Cancer in the United States. Clin Gastroenterol Hepatol 2021:S1542-3565(21)01054-5. [PMID: 34624563 DOI: 10.1016/j.cgh.2021.09.039] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Gheorghe DC, Ilie-Mihai RM, Stefan-van Staden RI, Lungu-Moscalu A, van Staden JKF. Fast screening method for early diagnostic of gastric cancer based on utilization of a chitosan - S-doped graphene - based needle stochastic sensors. J Pharm Biomed Anal 2022;214:114725. [PMID: 35303648 DOI: 10.1016/j.jpba.2022.114725] [Reference Citation Analysis]
3 Wang Z, Lv Z, Ding H, Xu Q, Sun L, Jing J, Yuan Y. Role of serum EBV-VCA IgG detection in assessing gastric cancer risk and prognosis in Northern Chinese population. Cancer Med 2018;7:5760-74. [PMID: 30306734 DOI: 10.1002/cam4.1792] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
4 Yan GW, Deng JF, Bhetuwal A, Yang GQ, Fu QS, Chen H, Hu N, Zeng H, Fan XP, Yan GW, Wu XL. A case report and literature review of barium sulphate aspiration during upper gastrointestinal examination. Medicine (Baltimore) 2017;96:e8821. [PMID: 29381987 DOI: 10.1097/MD.0000000000008821] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 2.8] [Reference Citation Analysis]
5 Wang Y, Zhu Z, Liu Z, Zhao Z, Xue X, Li X, Li P, Rong G, Ma Y. Diagnostic value of serum pepsinogen I, pepsinogen II, and gastrin-17 levels for population-based screening for early-stage gastric cancer. J Int Med Res 2020;48:300060520914826. [PMID: 32228342 DOI: 10.1177/0300060520914826] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Cai Q, Zhu C, Yuan Y, Feng Q, Feng Y, Hao Y, Li J, Zhang K, Ye G, Ye L, Lv N, Zhang S, Liu C, Li M, Liu Q, Li R, Pan J, Yang X, Zhu X, Li Y, Lao B, Ling A, Chen H, Li X, Xu P, Zhou J, Liu B, Du Z, Du Y, Li Z; Gastrointestinal Early Cancer Prevention & Treatment Alliance of China (GECA). Development and validation of a prediction rule for estimating gastric cancer risk in the Chinese high-risk population: a nationwide multicentre study. Gut 2019;68:1576-87. [PMID: 30926654 DOI: 10.1136/gutjnl-2018-317556] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
7 Bang CS, Lee JJ, Baik GH. Prediction of Chronic Atrophic Gastritis and Gastric Neoplasms by Serum Pepsinogen Assay: A Systematic Review and Meta-Analysis of Diagnostic Test Accuracy. J Clin Med 2019;8:E657. [PMID: 31083485 DOI: 10.3390/jcm8050657] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
8 Zhou Q, Chen Y, Pan J, Zhou L, Lin J. Application of a novel scoring system for gastric cancer opportunistic screening in hospital visits. BMC Gastroenterol 2022;22. [DOI: 10.1186/s12876-022-02315-9] [Reference Citation Analysis]
9 Su X, Ye Z, Wang Z, Long Y, Qiu M, He C. Epstein-Barr virus infection associated with pepsinogens and Helicobacter pylori infection in patients with gastric cancer. Virus Res 2018;256:1-5. [PMID: 30053417 DOI: 10.1016/j.virusres.2018.07.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
10 Hamid M, Ullah W, Ur Rashid M, Amjad W, Mukhtar M, Hurairah A. An Esophagogram or Tracheobronchogram? A Review of Barium Sulfate Aspiration. J Investig Med High Impact Case Rep 2018;6:2324709618802872. [PMID: 30302346 DOI: 10.1177/2324709618802872] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
11 Xie Y, Shi L, He X, Luo Y. Gastrointestinal cancers in China, the USA, and Europe. Gastroenterol Rep (Oxf) 2021;9:91-104. [PMID: 34026216 DOI: 10.1093/gastro/goab010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Wang R, Chen XZ. Prevalence of atrophic gastritis in southwest China and predictive strength of serum gastrin-17: A cross-sectional study (SIGES). Sci Rep 2020;10:4523. [PMID: 32161305 DOI: 10.1038/s41598-020-61472-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
13 Su H, Ren W, Zhang D. Research progress on exosomal proteins as diagnostic markers of gastric cancer (review article). Clin Exp Med. [DOI: 10.1007/s10238-022-00793-5] [Reference Citation Analysis]
14 Zhang L, Niu Y, Lv YJ, Wu LF, Hu QL, Huang R, Xu RJ. Preliminary Study on Reference Interval of Serum Pepsinogen in Healthy Subjects. Patient Prefer Adherence 2021;15:2725-30. [PMID: 34916782 DOI: 10.2147/PPA.S330656] [Reference Citation Analysis]
15 Ye DM, Xu G, Ma W, Li Y, Luo W, Xiao Y, Liu Y, Zhang Z. Significant function and research progress of biomarkers in gastric cancer. Oncol Lett 2020;19:17-29. [PMID: 31897111 DOI: 10.3892/ol.2019.11078] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
16 Epplein M, Butt J, Zhang Y, Hendrix LH, Abnet CC, Murphy G, Zheng W, Shu XO, Tsugane S, Qiao YL, Taylor PR, Shimazu T, Yoo KY, Park SK, Kim J, Jee SH, Waterboer T, Pawlita M, You WC, Pan KF. Validation of a Blood Biomarker for Identification of Individuals at High Risk for Gastric Cancer. Cancer Epidemiol Biomarkers Prev 2018;27:1472-9. [PMID: 30158280 DOI: 10.1158/1055-9965.EPI-18-0582] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
17 Huang RJ, Hwang JH. Improving the Early Diagnosis of Gastric Cancer. Gastrointest Endosc Clin N Am 2021;31:503-17. [PMID: 34053636 DOI: 10.1016/j.giec.2021.03.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Song M, Camargo MC, Weinstein SJ, Murphy G, Freedman ND, Koshiol J, Stolzenberg-Solomon RZ, Abnet CC, Männistö S, Albanes D, Rabkin CS. Serum pepsinogen 1 and anti-Helicobacter pylori IgG antibodies as predictors of gastric cancer risk in Finnish males. Aliment Pharmacol Ther 2018;47:494-503. [PMID: 29243850 DOI: 10.1111/apt.14471] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
19 Tabatabaiefar MA, Moridnia A. Gastrointestinal Cancers. In: Mehdipour P, editor. Cancer Genetics and Psychotherapy. Cham: Springer International Publishing; 2017. pp. 589-625. [DOI: 10.1007/978-3-319-64550-6_12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
20 Fang J, Du YQ, Liu WZ, Ren JL, Li YQ, Chen XY, Lv NH, Chen YX, Lv B; Chinese Society of Gastroenterology, Chinese Medical Association. Chinese consensus on chronic gastritis (2017, Shanghai): 2017 Chinese consensus on CG. Journal of Digestive Diseases 2018;19:182-203. [DOI: 10.1111/1751-2980.12593] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
21 Huang RJ, Park S, Shen J, Longacre T, Ji H, Hwang JH. Pepsinogens and Gastrin Demonstrate Low Discrimination for Gastric Precancerous Lesions in a Multi-Ethnic United States Cohort. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00011-2. [PMID: 33434656 DOI: 10.1016/j.cgh.2021.01.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Cao M, Li H, Sun D, Lei L, Ren J, Shi J, Li N, Peng J, Chen W. Classifying risk level of gastric cancer: Evaluation of questionnaire-based prediction model. Chin J Cancer Res 2020;32:605-13. [PMID: 33223755 DOI: 10.21147/j.issn.1000-9604.2020.05.05] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Gao X, Jia Y, Xu H, Li Y, Zhu Q, Wei C, Hou J, Li D, Wang W, Li Z, Guo R, Jia J, Wu Y, Wei Z, Qi X, Li Y. Association between serum pepsinogen and atherosclerotic cardiovascular disease. Nutr Metab Cardiovasc Dis 2021;31:169-77. [PMID: 33127250 DOI: 10.1016/j.numecd.2020.07.045] [Reference Citation Analysis]
24 Guo K, Li Z, Qiu B, Hu B, Yi S, Hong T. Analysis of Gastric Diseases and Their Symptoms Based on Indexes of Pepsinogen I (PGI) and Pepsinogen II (PGII): Take 1106 Patients as Samples. Cellular Microbiology 2022;2022:1-6. [DOI: 10.1155/2022/8393351] [Reference Citation Analysis]
25 Tong Y, Wang H, Zhao Y, He X, Xu H, Li H, Shuai P, Gong L, Wu H, Xu H, Luo Y, Wang D, Liu S, Song Z. Diagnostic Value of Serum Pepsinogen Levels for Screening Gastric Cancer and Atrophic Gastritis in Asymptomatic Individuals: A Cross-Sectional Study. Front Oncol 2021;11:652574. [PMID: 34504781 DOI: 10.3389/fonc.2021.652574] [Reference Citation Analysis]
26 Shen M, Wang H, Wei K, Zhang J, You C. Five common tumor biomarkers and CEA for diagnosing early gastric cancer: A protocol for a network meta-analysis of diagnostic test accuracy. Medicine (Baltimore) 2018;97:e0577. [PMID: 29742692 DOI: 10.1097/MD.0000000000010577] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
27 Takahashi Y, Yamamichi N, Kubota D, Shimamoto T, Nagao S, Sakuma N, Sakaguchi Y, Yakabi S, Tsuji Y, Wada R, Mitsushima T, Ichinose M, Fujishiro M. Risk factors for gastric cancer in Japan in the 2010s: a large, long-term observational study. Gastric Cancer. [DOI: 10.1007/s10120-021-01273-7] [Reference Citation Analysis]
28 Shen H, Xiong K, Wu X, Cheng S, Lou Q, Jin H, Zhang X. The Diagnostic Value of Serum Gastrin-17 and Pepsinogen for Gastric Cancer Screening in Eastern China. Gastroenterol Res Pract 2021;2021:6894248. [PMID: 33936196 DOI: 10.1155/2021/6894248] [Reference Citation Analysis]
29 Chiang TH, Chiu SY, Chen SL, Yen AM, Fann JC, Liu CY, Chou CK, Chiu HM, Shun CT, Wu MS, Lin JT, Lee YC, Chen TH, Lin MW. Serum Pepsinogen as a Predictor for Gastric Cancer Death: A 16-Year Community-based Cohort Study. J Clin Gastroenterol. 2019;53:e186-e193. [PMID: 29369241 DOI: 10.1097/mcg.0000000000000992] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
30 Jiang W, Sun G, Zhang Y, Hu Z, Wen X, Men S, Xing Z, Zhang S, Huang B, Wang C. Simultaneous determination of gastric cancer biomarkers pepsinogen PGI/PGII using element tagged immunoassay coupled with inductively coupled plasma mass spectrometry detection. J Clin Lab Anal 2020;34:e23287. [PMID: 32147885 DOI: 10.1002/jcla.23287] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
31 Xu Y, Miremadi A, Link A, Malfertheiner P, Fitzgerald RC, Bornschein J. Feasibility of combined screening for upper gastrointestinal adenocarcinoma risk by serology and Cytosponge testing: the SUGAR study. J Clin Pathol 2019;72:825-9. [PMID: 31235543 DOI: 10.1136/jclinpath-2019-205700] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Cai HL, Tong YL. Association of serum pepsinogen with degree of gastric mucosal atrophy in an asymptomatic population. World J Clin Cases 2021; 9(31): 9431-9439 [PMID: 34877278 DOI: 10.12998/wjcc.v9.i31.9431] [Reference Citation Analysis]
33 Hu Y, Bao H, Jin H, Zhao J, Xu Y, Huang X, Liu S, Lu B. Performance evaluation of four prediction models for risk stratification in gastric cancer screening among a high-risk population in China. Gastric Cancer 2021. [PMID: 34152518 DOI: 10.1007/s10120-021-01204-6] [Reference Citation Analysis]
34 Liu X, Zhang M, Luo R, Mo K, He X. Significance of pepsinogen in screening for gastric intestinal metaplasia in Guangdong, China. J Int Med Res 2021;49:300060521990495. [PMID: 33631996 DOI: 10.1177/0300060521990495] [Reference Citation Analysis]
35 Shen S, Li H, Liu J, Sun L, Yuan Y. The panoramic picture of pepsinogen gene family with pan-cancer. Cancer Med 2020;9:9064-80. [PMID: 33067881 DOI: 10.1002/cam4.3489] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
36 Fan X, Qin X, Zhang Y, Li Z, Zhou T, Zhang J, You W, Li W, Pan K. Screening for gastric cancer in China: Advances, challenges and visions. Chin J Cancer Res 2021;33:168-80. [PMID: 34158737 DOI: 10.21147/j.issn.1000-9604.2021.02.05] [Reference Citation Analysis]
37 Zhao AJ, Qian YY, Sun H, Hou X, Pan J, Liu X, Zhou W, Chen YZ, Jiang X, Li ZS, Liao Z. Screening for gastric cancer with magnetically controlled capsule gastroscopy in asymptomatic individuals. Gastrointest Endosc. 2018;88:466-474.e1. [PMID: 29753039 DOI: 10.1016/j.gie.2018.05.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 6.5] [Reference Citation Analysis]
38 Lahner E, Marzinotto I, Lampasona V, Dottori L, Bazzigaluppi E, Brigatti C, Secchi M, Piemonti L, Conti L, Pilozzi E, Davidson HW, Wenzlau JM, Annibale B. Autoantibodies Toward ATP4A and ATP4B Subunits of Gastric Proton Pump H+,K+-ATPase Are Reliable Serological Pre-endoscopic Markers of Corpus Atrophic Gastritis. Clin Transl Gastroenterol 2020;11:e00240. [PMID: 33031196 DOI: 10.14309/ctg.0000000000000240] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Zheng S, Hu R, Yu X, Chen L, BinrongWang, Qin Y, Zhou X, Wang Y, Huang B, Fang H, Liu P. Development of a time-resolved fluorescence immunoassay based on immunomagnetic beads for gastrin-17. J Immunol Methods 2021;499:113179. [PMID: 34728217 DOI: 10.1016/j.jim.2021.113179] [Reference Citation Analysis]
40 Wang Z, Mo TM, Tian L, Chen JQ. Gastrin-17 Combined with CEA, CA12-5 and CA19-9 Improves the Sensitivity for the Diagnosis of Gastric Cancer. Int J Gen Med 2021;14:8087-95. [PMID: 34795515 DOI: 10.2147/IJGM.S335985] [Reference Citation Analysis]
41 Necula L, Matei L, Dragu D, Neagu AI, Mambet C, Nedeianu S, Bleotu C, Diaconu CC, Chivu-Economescu M. Recent advances in gastric cancer early diagnosis. World J Gastroenterol 2019; 25(17): 2029-2044 [PMID: 31114131 DOI: 10.3748/wjg.v25.i17.2029] [Cited by in CrossRef: 76] [Cited by in F6Publishing: 70] [Article Influence: 25.3] [Reference Citation Analysis]
42 Zhang QY, Lv Z, Sun LP, Dong NN, Xing CZ, Yuan Y. Clinical significance of serum markers reflecting gastric function and H. pylori infection in colorectal cancer. J Cancer 2019;10:2229-36. [PMID: 31258726 DOI: 10.7150/jca.27134] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
43 Boubrik F, Belmouden A, Kadmiri NE. Potential Non-invasive Biomarkers of Helicobacter pylori-Associated Gastric Cancer. J Gastrointest Cancer 2021. [PMID: 34767179 DOI: 10.1007/s12029-021-00734-7] [Reference Citation Analysis]
44 Ji R, Zhang Z, Zhang J, Wu Z, Li M, Ye Y, Li X, An F, Xu C, Lu L, Fan P, Chen Z, Guo Q, Wang Y, Wang X, Li Y, Zhang J, Guan Q, Hu X, Yang T, Liu J, Qiao L, Zheng Y, Zhou Y. Cohort Profile: A population-based cohort for the study of gastric cancer in northwest area of China (Wuwei Cohort). Int J Epidemiol 2021:dyab083. [PMID: 34143880 DOI: 10.1093/ije/dyab083] [Reference Citation Analysis]
45 Liu WJ, Lv Z, Liu JW, Xu Q, Ding HX, Yuan Y. LncRNAs adjacent to pepsinogen C in gastric diseases and diagnostic efficiencies of joint detection in gastric diseases. Future Oncol 2020;16:655-63. [PMID: 32242461 DOI: 10.2217/fon-2019-0833] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
46 Yin L, Xu G, Zhu Y, Wang Y. Expression of miR-23a and miR-135 and tumor markers in gastric cancer patients and the significance in diagnosis. Oncol Lett 2019;18:5853-8. [PMID: 31788058 DOI: 10.3892/ol.2019.10943] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
47 Du Y, Zhu H, Liu J, Li J, Chang X, Zhou L, Chen M, Lu N, Li Z. Consensus on eradication of Helicobacter pylori and prevention and control of gastric cancer in China (2019, Shanghai). J Gastroenterol Hepatol. 2020;35:624-629. [PMID: 31788864 DOI: 10.1111/jgh.14947] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
48 Fu S, Hu QL, Zhang L, Li ZJ. Effects of different pepsinogen cut offs in the screening of apparently healthy people. Clin Chem Lab Med 2022. [PMID: 35421289 DOI: 10.1515/cclm-2022-0080] [Reference Citation Analysis]